Scientists at Harvard's Wyss Institute developed a lung-on-a-chip device that simulates human lung function without animal testing, though adoption remains slow. The FDA recently required a pharmaceutical company to use organ-on-chip data instead of animal data for a clinical trial, signaling a potential shift toward these alternative methods in drug development and toxicology research.